Fei Xu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Epithelial Mesenchymal Transition

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jingtao Zhang, Haitao Li, Minghao Guo, Jing Zhang, Guangming Zhang, Ning Sun, Yuyuan Feng, Wen-Qiang Cui, Fei Xu
FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma. Immunotherapy 15 (4) (2023)
Jingtao Zhang, Haitao Li, Minghao Guo, Jing Zhang, Guangming Zhang, Ning Sun, Yuyuan Feng, Wen-Qiang Cui, Fei Xu
FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma. Immunotherapy (2023)
Jingtao Zhang, Haitao Li, Minghao Guo, Jing Zhang, Guangming Zhang, Ning Sun, Yuyuan Feng, Wen-Qiang Cui, Fei Xu
FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma. Immunotherapy 15 (4) (2023)
Jingtao Zhang, Haitao Li, Minghao Guo, Jing Zhang, Guangming Zhang, Ning Sun, Yuyuan Feng, Wen-Qiang Cui, Fei Xu
FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma. Immunotherapy 15 (4) (2023)
Fei Xu, Wen-Qiang Cui, Cun Liu, Fubin Feng, Ruijuan Liu, Jingtao Zhang, Chang-Gang Sun
Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio (2022)